Biodegradation of sulfamethoxazole by individual and mixed bacteria

Applied Microbiology and Biotechnology

Volumn 91, Issue 1, 2011, Pages 211-218

  Larcher, Simone ^a   Yargeau, Viviane ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

Antibiotics; Biodegradation; Mixed cultures; R. equi; Sulfamethoxazole (SMX)

Indexed keywords

ACTIVATED SLUDGE; AQUATIC ENVIRONMENTS; BACILLUS SUBTILIS; BACTERIAL CULTURES; DEGRADATION PATHWAYS; INOCULA; MICROBIAL POPULATIONS; MIXED BACTERIA; MIXED CULTURES; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS PUTIDA; PURE CULTURE; R. EQUI; RHODOCOCCUS; RHODOCOCCUS EQUI; RHODOCOCCUS ERYTHROPOLIS; SULFAMETHOXAZOLE; SYNERGISTIC EFFECT; WASTEWATER TREATMENT PLANTS;

ANTIBIOTICS; BACTERIOLOGY; BIODEGRADATION; DEGRADATION; GLUCOSE; METABOLISM; METABOLITES; TOXICITY; WASTEWATER; WASTEWATER DISPOSAL; WASTEWATER TREATMENT; WATER TREATMENT PLANTS;

BACTERIA;

GLUCOSE; SULFAMETHOXAZOLE;

ACTIVATED SLUDGE; ANTIBIOTIC RESISTANCE; ANTIBIOTICS; ANTIMICROBIAL ACTIVITY; BACTERIUM; BIODEGRADATION; EXCRETION; LABORATORY METHOD; METABOLITE; MICROBIAL ACTIVITY; MICROBIAL COMMUNITY; POLLUTANT REMOVAL; SURFACE WATER; WASTE TREATMENT; WASTEWATER;

ACTIVATED SLUDGE; ARTICLE; BACILLUS SUBTILIS; BACTERIAL GROWTH; BACTERIAL METABOLISM; BACTERIUM CULTURE; BIODEGRADATION; CONTROLLED STUDY; DRUG DEGRADATION; DRUG METABOLISM; ENZYME SYNTHESIS; HUMAN; NONHUMAN; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS PUTIDA; RHODOCOCCUS; RHODOCOCCUS EQUI; RHODOCOCCUS ERYTHROPOLIS; RHODOCOCCUS RHODOCROUS; RHODOCOCCUS ZOPFII; WASTE WATER MANAGEMENT;

ANTI-BACTERIAL AGENTS; BACTERIA; BIODEGRADATION, ENVIRONMENTAL; ENVIRONMENTAL REMEDIATION; SEWAGE; SULFAMETHOXAZOLE; WATER POLLUTANTS, CHEMICAL;

BACILLUS SUBTILIS; BACTERIA (MICROORGANISMS); PSEUDOMONAS AERUGINOSA; PSEUDOMONAS PUTIDA; RHODOCOCCUS; RHODOCOCCUS EQUI; RHODOCOCCUS ERYTHROPOLIS; RHODOCOCCUS ZOPFII;

EID: 79959205506     PISSN: 01757598     EISSN: 14320614     Source Type: Journal    
DOI: 10.1007/s00253-011-3257-8     Document Type: Article

References (39)

1. Al-Ahmad A, Daschner FD, Kümmerer K (1999) Biodegradability of cefotiam, ciprofloxacin, meropenem, penicillin G, and sulfamethoxazole and inhibition of waste water bacteria. Arch Environ Contam Toxicol 37(2):158-163 (Pubitemid 29357886)
2. Alexy R, Kumpel T, Kummerer K (2004) Assessment of degradation of 18 antibiotics in the Closed Bottle Test. Chemosphere 57(6):505-512 (Pubitemid 39179769)
3. Andersson DI (2003) Persistence of antibiotic resistant bacteria. Curr Opin Microbiol 6(5):452-456
4. Batt AL, Kim S, Aga DS (2007) Comparison of the occurrence of antibiotics in four full-scale wastewater treatment plants with varying designs and operations. Chemosphere 68(3):428-435 (Pubitemid 46574873)
5. Benedict RG, Carlson DA (1971) Aerobic heterotrophic bacteria in activated sludge. Water Res 5(11):1023-1030
6. Benotti MJ, Trenholm RA, Vanderford BJ, Holady JC, Stanford BD, Snyder SA (2009) Pharmaceuticals and endocrine disrupting compounds in U.S. drinking water. Environ Sci Technol 43(3):597-603. doi:10.1021/es801845a
7. BRENDA The Comprehensive Enzyme Information System http://www.brenda- enzymes.org/index.php4. Accessed 27 Feb 2011
8. Carballa M, Omil F, Lema JM, Llompart M, Garcia-Jares C, Rodriguez I, Gomez M, Ternes T (2004) Behavior of pharmaceuticals, cosmetics and hormones in a sewage treatment plant. Water Res 38(12):2918-2926 (Pubitemid 38829583)
9. Cavallucci S (2007) Top 200: what's topping the charts in prescription drugs this year? Pharmacy Practice, Canadian Healthcare Network. http://www.imshealthcanada.com/vgn/images/portal/cit-40000873/13/31/ 8286270612-TOP200-07-final.pdf. Accessed 26 Feb 2008
10. Costanzo SD, Murby J, Bates J (2005) Ecosystem response to antibiotics entering the aquatic environment. Mar Pollut Bull 51(1-4):218-223 (Pubitemid 40341617)
11. Daughton CG (ed) (2003) Chemicals from pharmaceuticals and personal care products, vol 1. Water: sciences and issues. MacMillan Reference, New York
12. Daughton CG, Ternes TA (1999) Pharmaceuticals and personal care products in the environment: agents of subtle change? Environ Health Perspect Suppl 107(S6):907-938
13. Drillia P, Dokianakis SN, Fountoulakis MS, Kornaros M, Stamatelatou K, Lyberatos G (2005) On the occasional biodegradation of pharmaceuticals in the activated sludge process: the example of the antibiotic sulfamethoxazole. J Hazard Mater 122(3):259-265 (Pubitemid 40828492)
14. Gartiser S, Urich E, Alexy R, Kümmerer K (2007) Ultimate biodegradation and elimination of antibiotics in inherent tests. Chemosphere 67(3):604-613 (Pubitemid 46107583)
15. Göbel A, McArdell CS, Joss A, Siegrist H, Giger W (2007) Fate of sulfonamides, macrolides, and trimethoprim in different wastewater treatment technologies. Sci Total Environ 372(2-3):361-371 (Pubitemid 46037769)
16. Goni-Urriza M, Capdepuy M, Arpin C, Raymond N, Caumette P, Quentin C (2000) Impact of an urban effluent on antibiotic resistance of riverine Enterobacteriaceae and Aeromonas spp. Appl Environ Microbiol 66(1):125-132. doi:10.1128/aem.66.1.125-132.2000 (Pubitemid 30030506)
17. Hirsch R, Ternes T, Haberer K, Kratz K-L (1999) Occurrence of antibiotics in the aquatic environment. Sci Total Environ 225(1-2):109-118 (Pubitemid 29148051)
18. Janke D, Fritsche W (1985) Nature and significance of microbial cometabolism of xenobiotics. J Basic Microbiol 25(9):603-619 (Pubitemid 16197978)
19. Jones O, Voulvoulis N, Lester JN (2005) Human pharmaceuticals in wastewater treatment processes. Crit Rev Environ Sci Tech 35(4):401-427 (Pubitemid 40965518)
20. Jorgensen SE, Halling-Sorensen B (2000) Drugs in the environment. Chemosphere 40(7):691-699
21. Joss A, Keller E, Alder AC, Göbel A, McArdell CS, Ternes T, Siegrist H (2005) Removal of pharmaceuticals and fragrances in biological wastewater treatment. Water Res 39(14):3139-3152 (Pubitemid 41138819)
22. Joss A, Zabczynski S, Gobel A, Hoffmann B, Loffler D, McArdell CS, Ternes TA, Thomsen A, Siegrist H (2006) Biological degradation of pharmaceuticals in municipal wastewater treatment: proposing a classification scheme. Water Res 40(8):1686-1696
23. Kolpin DW, Furlong ET, Meyer MT, Thurman EM, Zaugg SD, Barber LB, Buxton HT (2002) Pharmaceuticals, hormones, and other organic wastewater contaminants in U.S. streams, 1999-2000: a national reconnaissance. Environ Sci Technol 36 (6):1202-1211 (Pubitemid 34228893)
24. Kümmerer K (2009a) Antibiotics in the aquatic environment - a review-part I. Chemosphere 75(4):417-434
25. Kümmerer K (2009b) Antibiotics in the aquatic environment - a review-part II. Chemosphere 75(4):435-441
26. Kümmerer K (2009c) The presence of pharmaceuticals in the environment due to human use - present knowledge and future challenges. J Environ Manage 90(8):2354-2366
27. Larkin MJ, Kulakov LA, Allen CCR (2005) Biodegradation and Rhodococcus - masters of catabolic versatility. Curr Opin Biotechnol 16(3):282-290. doi:10.1016/j.copbio.2005.04.007 (Pubitemid 40806465)
28. Martínková L, Kren V, Cvak L, Ovesná M, Prepechalová I (2000) Hydrolysis of lysergamide to lysergic acid by Rhodococcus equi A4. J Biotechnol 84(1):63-66. doi:10.1016/s0168-1656(00)00332-1
29. Martínková L, Uhnáková B, Pátek M, Nesvera J, Kren V (2009) Biodegradation potential of the genus Rhodococcus. Environ Int 35(1):162-177. doi:10.1016/j.envint.2008.07.018
30. Miège C, Choubert JM, Ribeiro L, Eusèbe M, Coquery M (2009) Fate of pharmaceuticals and personal care products in wastewater treatment plants - conception of a database and first results. Environ Pollut 157(5):1721-1726
31. Peng X, Wang Z, Kuang W, Tan J, Li K (2006) A preliminary study on the occurrence and behavior of sulfonamides, ofloxacin and chloramphenicol antimicrobials in wastewaters of two sewage treatment plants in Guangzhou, China. Sci Total Environ 371(1-3):314-322 (Pubitemid 44666119)
32. Perez S, Eichhorn P, Aga DS (2005) Evaluating the biodegradability of sulfamethazine, sulfamethoxazole, sulfathiazole, and trimethoprim at different stages of sewage treatment. Environ Toxicol Chem 24(6):1361-1367 (Pubitemid 40696152)
33. Rani A, Porwal S, Sharma R, Kapley A, Purohit HJ, Kalia VC (2008) Assessment of microbial diversity in effluent treatment plants by culture dependent and culture independent approaches. Bioresour Technol 99(15):7098-7107
34. Reinthaler FF, Posch J, Feierl G, Wust G, Haas D, Ruckenbauer G, Mascher F, Marth E (2003) Antibiotic resistance of E. coli in sewage and sludge. Water Res 37(8):1685-1690 (Pubitemid 36403613)
35. Seviour R, Kragelund C, Kong Y, Eales K, Nielsen J, Nielsen P (2008) Ecophysiology of the Actinobacteria in activated sludge systems. Antonie Leeuwenhoek 94(1):21-33
36. Ternes T, Janex-Habibi M-L, Knacker T, Kreuzinger N, Siegrist H (2006) Assessment of technologies for the removal of pharmaceuticals and personal care products in sewage and drinking water facilities to improve the indirect potable water reuse (POSEIDON Final Report-EU Research Programme) http://poseidon.bafg. de/servlet/is/2888/. Accessed 1 Feb 2008
37. Volkmann H, Schwartz T, Bischoff P, Kirchen S, Obst U (2004) Detection of clinically relevant antibiotic-resistance genes in municipal wastewater using real-time PCR (TaqMan). J Microbiol Meth 56(2):277-286 (Pubitemid 38117186)
38. Xu W, Zhang G, Li X, Zou S, Li P, Hu Z, Li J (2007) Occurrence and elimination of antibiotics at four sewage treatment plants in the Pearl River Delta (PRD), South China. Water Res 41(19):4526-4534 (Pubitemid 47599590)
39. Yargeau V, Lopata A, Metcalfe C (2007) Pharmaceuticals in the Yamaska River, Quebec, Canada. Water Qual Res J Can 42(4):231-239